Catalyst Wire Dossier Catalyst Wire Dossier

Drospirenone/Ethynilestradiol

Drospirenone/Ethynilestradiol · Eurofarma Laboratorios S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Drospirenone/Ethynilestradiol, covering 2017-09-21 to 2017-09-21. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol [Phase 3]

See pricing